欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IE/H/0858/002
药品名称Methylphenidathydrochlorid Actavis 27 mg Retardtabletten
活性成分
    • methylphenidate hydrochloride 27.0 mg
剂型Prolonged-release tablet
上市许可持有人splitting procedure: DE/H/4528/001/New splitted procedure number is UK/H/6733/001-004 Actavis Group PTC ehf. Reykjavíkurvegi 76-78 220 Hafnarfjörður Iceland
参考成员国 - 产品名称Ireland (IE)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
许可日期2018/01/30
最近更新日期2020/03/05
药物ATC编码
    • N06BA04 methylphenidate
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase